Literature DB >> 9087922

Immunoblot analysis of the immunoglobulin G response to Ehrlichia canis in dogs: an international survey.

B C Hegarty1, M G Levy, R F Gager, E B Breitschwerdt.   

Abstract

Historically, considerable variation has been reported in the type and severity of clinical and hematologic abnormalities associated with canine ehrlichiosis. Because of difficulties associated with the isolation of intracellular monocytic Ehrlichia species in tissue culture systems, few E. canis isolates are available for comparative microbiologic studies. To address the issue of potential E. canis antigenic diversity in different regions of the world, dog sera reactive by indirect fluorescent antibody testing to E. canis (Florida) antigen were obtained from France, Israel, Italy, the United States, the Virgin Islands, and Zimbabwe. Ehrlichia canis proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, and at least 5 sera from each region were stained by western immunoblotting. Antibody immunodominance was scored based upon staining intensity. There was relative homogeneity in the immunogenic protein reactions to E. canis antigens. Of the 58 E. canis reactive sera, 54 samples resulted in immunoblot patterns indicative of chronic ehrlichiosis. Four reactive sera (reciprocal titers of 160-2,560) did not recognize any genus-specific antigens resulting in protein bands between 22 and 29 kD, indicating serologic cross-reactivity with other microorganisms. Relatively homogenous immunoblot patterns, consistent with the reported immunoblot response of dogs with experimental chronic ehrlichiosis, were observed with sera from Arizona, France, Israel, North Carolina, Texas, and the Virgin Islands. In contrast, unique major proteins were observed in dog sera from Italy and Zimbabwe. Our results indicate that although relatively homogeneous, antigenic diversity may exist among E. canis organisms in different regions of the world.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087922     DOI: 10.1177/104063879700900106

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

Review 1.  Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis.

Authors:  S Harrus; T Waner; H Bark; F Jongejan; A W Cornelissen
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Coinfection with three Ehrlichia species in dogs from Thailand and Venezuela with emphasis on consideration of 16S ribosomal DNA secondary structure.

Authors:  J Suksawat; C Pitulle; C Arraga-Alvarado; K Madrigal; S I Hancock; E B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Genetic and antigenic diversities of major immunoreactive proteins in globally distributed Ehrlichia canis strains.

Authors:  Xiaofeng Zhang; Tian Luo; Avi Keysary; Gad Baneth; Simone Miyashiro; Carmela Strenger; Trevor Waner; Jere W McBride
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

6.  Molecular detection of Ehrlichia canis in dogs in Malaysia.

Authors:  Mojgan Nazari; Sue Yee Lim; Mahira Watanabe; Reuben S K Sharma; Nadzariah A B Y Cheng; Malaika Watanabe
Journal:  PLoS Negl Trop Dis       Date:  2013-01-03

7.  Seroprevalence of Canine Ehrlichiosis and Microscopic Screening for Canine Babesiosis in Dogs in Harare, Zimbabwe, 2016-2017.

Authors:  Solomon Dhliwayo; Brighton Chihambakwe; Knowledge Taonezvi; Silvester M Chikerema; Musavengana T Tivapasi; Davies M Pfukenyi
Journal:  Vet Med Int       Date:  2019-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.